Lili Ataie

Dr. Lili Ataie

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
LALayan Akkielah
Layan Akkielah
WLWayne Leung
Wayne Leung
SWSerena Wang
Serena Wang
LALili Ataie
Lili Ataie
AXAnargyros Xenocostas
Anargyros Xenocostas
MSMohammadReza Rahimi Shahmirzadi
MohammadReza Rahimi Shahmirzadi
Hematopoietic stem cell transplant (HSCT) recipients are at high risk for opportunistic infections due to profound immunosuppression and graft-versus-host disease (GvHD). Molds and nontuberculous mycobacteria (NTM) pose diagnostic and therapeutic challenges, especially when infections overlap. A 42-year-old woman with prior allogeneic HSCT for acute myeloid leukemia (AML) developed pulmonary infections with Microascus spp. and Mycobacterium chimaera, later complicated by Aspergillus calidoustus and RSV infection. Initial therapy included voriconazole, amphotericin B, and a macrolide-based multidrug regimen for NTM. Modifications were required for drug resistance and hepatotoxicity. Despite partial response, recurrent fungal infection necessitated prolonged antifungal therapy, including adjunctive inhaled amphotericin B and terbinafine. Ultimately, progressive bronchiolitis obliterans prompted bilateral lung transplantation. Explant pathology revealed necrotizing granulomas positive for NTM and Microascus spp. Post-transplant prophylaxis with voriconazole, rifabutin, azithromycin, and inhaled amikacin prevented recurrence, and the patient remained clinically stable at 6-month follow-up. This case illustrates the complexity of managing overlapping mold and NTM infections in HSCT recipients, highlighting the need for individualized, multidisciplinary care. Therapeutic drug monitoring, careful adjustment for drug–drug interactions, and the use of adjunctive inhaled antifungals were critical to achieving a favorable outcome.

29 June 2026 in Journal of the Association of Medical Microbiology and Infectious Disease Canada
Verified
Journal Article
Closed access
FKFabiana Kellen
Fabiana Kellen
LALili Ataie
Lili Ataie
FAFatimah AlMutawa
Fatimah AlMutawa
MSMichael Silverman
Michael Silverman
MSMohammadReza Rahimi Shahmirzadi
MohammadReza Rahimi Shahmirzadi
We report the case of a 23-year-old woman with tuberculous lymphadenitis diagnosed prior to pregnancy who developed paradoxical lymph node enlargement during pregnancy and again in the post-partum period. Despite completing a full 9-month course of standard anti-tuberculosis therapy, she experienced recurrent cervical lymphadenopathy and a transient pulmonary opacity following delivery. Extensive investigations, including repeat biopsies and cultures, excluded relapse or drug resistance, supporting the diagnosis of a paradoxical reaction. She was managed conservatively with drainage procedures, nonsteroidal anti-inflammatory drugs, and close monitoring, without the need for additional anti-tuberculosis medications or corticosteroids. Her lymphadenopathy resolved and she remained systemically well. This case is unique, as an extensive literature search in MEDLINE via PubMed and Embase from inception to September 2025 revealed no previously reported cases of paradoxical tuberculosis reactions occurring during pregnancy. This case underscores the importance of distinguishing paradoxical reactions from treatment failure, avoiding unnecessary therapy changes, and recognizing that conservative management is often sufficient in pregnancy and post-partum settings.

1 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMohammadReza Rahimi Shahmirzadi
MohammadReza Rahimi Shahmirzadi
DODanielle Ouellette
Danielle Ouellette
MIMartin C Igbokwe
Martin C Igbokwe
ASAlp Sener
Alp Sener
MGManal Gabril
Manal Gabril
LALili Ataie
Lili Ataie
A 51-year-old gentleman with complications from long-standing type 1 diabetes mellitus underwent simultaneous pancreas and pre-emptive kidney transplant at our center, with rabbit anti-thymocyte globulin and methylprednisolone induction. Three months post-transplant he presented for evaluation of a diffuse lichenoid cutaneous eruption. An extensive infectious workup was unrevealing, and skin punch biopsy showed interface vacuolar dermatitis, suggestive of graft-versus-host disease (GVHD) of the skin. The patient then developed acute transaminitis and neutropenia, and biopsies of the liver and bone marrow done subsequently also confirmed GVHD of these organs, with microchimerism assay on the bone marrow showing 43% of the T-cells were of donor origin. The patient improved with initiation of systemic and topical corticosteroids. Although a rare entity in solid organ transplantation, this case highlights the importance of considering solid organ transplant graft-versus-host disease (SOT-GVHD), particularly in patients receiving organs with a larger volume of passenger donor T-lymphocytes, such as is seen with intestinal, liver, and pancreas transplants.

12 August 2025 in Transplantology
Verified
Journal Article
Open access
PDF file
MSMohammadReza Rahimi Shahmirzadi
MohammadReza Rahimi Shahmirzadi
DODanielle Ouellette
Danielle Ouellette
MIMartin C Igbokwe
Martin C Igbokwe
ASAlp Sener
Alp Sener
MGManal Gabril
Manal Gabril
LALili Ataie
Lili Ataie
Background: Graft-versus-host disease (GVHD) is a rare but serious complication following solid organ transplantation (SOT), particularly in transplants involving organs with a high volume of passenger donor T-lymphocytes. This case highlights the clinical course and diagnostic challenges of GVHD following simultaneous pancreas and pre-emptive kidney transplantation. Methods: A 51-year-old male with long-standing type 1 diabetes mellitus underwent simultaneous pancreas and kidney transplantation with induction therapy using rabbit anti-thymocyte globulin and methylprednisolone. Three months post-transplant, he presented with a diffuse lichenoid cutaneous eruption. Diagnostic evaluation included an extensive infectious workup, skin punch biopsy, liver and bone marrow biopsies, and microchimerism assay. Results: Skin biopsy revealed interface vacuolar dermatitis consistent with cutaneous GVHD. Subsequent liver and bone marrow biopsies confirmed GVHD involvement, with microchimerism assay showing 43% donor-origin T-cells in the bone marrow. Initial treatment with systemic and topical corticosteroids led to temporary improvement. However, the patient developed bone marrow suppression, recurrent bacteremia, and invasive fungal infection, resulting in a prolonged ICU stay and ultimately death. Conclusions: This case underscores the importance of considering SOT-GVHD in patients receiving organs rich in donor lymphocytes, such as pancreas transplants. Early recognition and multidisciplinary management are critical to improving outcomes in this rare but life-threatening condition.

1 January 2026 in Sage Open Medical Case Reports
Verified
Journal Article
Open access
FKFabiana Kellen
Fabiana Kellen
MSMichael Silverman
Michael Silverman
ESEsfandiar Shojaei
Esfandiar Shojaei
MSMohammadReza Rahimi Shahmirzadi
MohammadReza Rahimi Shahmirzadi
LALili Ataie
Lili Ataie
Pyoderma gangrenosum is a rare neutrophilic dermatosis characterized by painful ulcerative skin lesions and a lack of definitive diagnostic tests. It is frequently mistaken for infectious conditions, often resulting in inappropriate antibiotic use and delayed immunosuppressive therapy. To describe the clinical and demographic characteristics of patients with pyoderma gangrenosum initially assessed in an infectious diseases setting and identify patterns that may aid in earlier diagnosis and management. A retrospective case series was conducted at a Cellulitis Clinic. Patients with a PARACELSUS score ⩾10 were included. Ten patients met inclusion criteria. Median age was 61.5 years; 60% were female and 90% Caucasian. Autoimmune diseases were present in 90%, mental health disorders in 50%, and endocrine abnormalities in 60%. Notably, 20% developed pyoderma gangrenosum at sites of healed scars—a rare presentation. Early recognition and multidisciplinary management are essential for timely treatment and improved outcomes.